NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology

 NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology

NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology

Shots:

  • NCCN collaborates with Pfizer to select ten projects to receive funding and strengthen innovations to improve the lives of people with cancer and adopt biosimilars in oncology
  • NCCN committed to exploring new avenues with the availability of affordable, effective treatment options in oncology
  • NCCN ORP will support preclinical, translational, clinical research, and quality improvement projects in oncology

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Tukuz

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post